Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd. (NASDAQ:DRTS), filed a Form 4 on August 25, 2026, disclosing transactions in ordinary shares dated August 21, 2026, made pursuant to a Rule 10b5-1 plan.

Key Highlights

  • Reporting person: Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd.
  • Exercise (Code M): 2,871 ordinary shares acquired at $2.98 per share on August 21, 2026.
  • Sale (Code S): 2,871 ordinary shares disposed of at $15.0028 per share on August 21, 2026.
  • Post-transaction ownership: 90,180 ordinary shares held directly following the reported transactions.
  • Rule 10b5-1 plan: The filing indicates the transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Alpha Tau Medical CFO Levy Reports Exercise and Same-Day Sale of Ordinary Shares

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Raphi Levy, serving as Chief Financial Officer of Alpha Tau Medical Ltd., reported two transactions in the company's ordinary shares, both dated August 21, 2026. The filing was signed and submitted on August 25, 2026.

The first transaction, coded "M," reflects the acquisition of 2,871 ordinary shares at a price of $2.98 per share, bringing Levy's directly held beneficial ownership to 93,051 shares. The second transaction, coded "S," reflects the disposition of 2,871 ordinary shares at $15.0028 per share. Following both transactions, the filing reported Levy's direct beneficial ownership at 90,180 ordinary shares. Both transactions carried a deemed execution date of August 21, 2026, matching the transaction date.

The filing indicates, via a checked box, that the transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The issuer is identified in the filing as Alpha Tau Medical Ltd., traded on NASDAQ under the ticker symbol DRTS. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

The Form 4 discloses that Alpha Tau Medical Ltd.'s CFO, Raphi Levy, exercised and sold 2,871 ordinary shares on August 21, 2026, under a Rule 10b5-1 plan, resulting in direct beneficial ownership of 90,180 ordinary shares.